Advertisement

Topics

Chroma Therapeutics Ltd Company Profile

20:09 EDT 22nd September 2017 | BioPortfolio

Chroma Therapeutics is a privately-held biotechnology company focused on the discovery and development of novel small molecule drugs based upon chromatin biology. Chroma is the first company to systematically assemble intellectual property in chromatin biology and has established a strong underpinning network of academic collaborators. Chroma aims to build substantial shareholder value through the creation of a broad and innovative product pipeline aimed at the treatment of high-prevalence cancers and inflammatory disorders. The company intends to achieve this goal by: focusing primarily on chromatin biology to build a balanced pipeline, by selecting a broad range of targets with differing mechanistic actions leveraging its links with leading chromatin researchers to provide a renewable pipeline of innovative programmes and a strong intellectual property portfolio focusing its strong medicinal chemistry capabilities on producing only first-in-class or best-in-class drugs, with excellent pharmaceutical properties utilising its novel cell accumulation technology to both enhance its core chromatin programmes, as well as building a highly valuable inflammation portfolio building substantial shareholder value through a balance of in-house development and selected strategic alliances which preserve significant downstream rights

Location

93 Milton Park
Abingdon
Oxfordshire
OX14 4RY
United Kingdom

Contact

Phone: 44 (0)1235 829120
Fax: 44 (0)1235 829125
Email: pa@chromatherapeutics. Com


News Articles [1524 Associated News Articles listed on BioPortfolio]

89 North Wins Prestigious International Award

BURLINGTON, Vt., Feb. 6, 2012 /PRNewswire/ -- After only three years in business, 89 North won the prestigious 2011 Prism Award from the International Society for Optics and Photonics (SPIE) on J...

Chroma Therapeutics Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 26072017] Prices from USD $250

SummaryChroma Therapeutics Ltd Chroma Therapeutics is a biotechnology company that discovers and develops small molecule drugs based on chromatin biology and novel cell accumulation approaches. The co...

Concurrent with BMS acquisition, IFM Therapeutics spins off IFM Therapeutics LLC

Innate immunity-focused IFM Therapeutics is spinning off its non-oncology assets into the new company IFM Therapeutics LLC.

Deals this week: Nabriva Therapeutics, LifeMine Therapeutics, Aldeyra Therapeutics

Nabriva Therapeutics plans to raise $80m through an underwritten public offering of shares of its common stock.

ProQR spins out Amylon Therapeutics for CNS therapeutics

ProQR Therapeutics has spun out Amylon Therapeutics, a privately-held company focused on the development of therapies for central nervous system (CNS) disorders, with seed funding from a group of inst...

Summit Therapeutics PLC (SMMT) and Orexigen Therapeutics (OREX) Head to Head Review

Summit Therapeutics PLC and Orexigen Therapeutics are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, in...

RaNA Therapeutics Relaunches as Translate Bio to Advance RNA Therapeutics

Tuesday, June 27th 2017 at 11:00am UTC — Company Expands Executive Leadership Team with Key Appointments in Early 2017 — CAMBRIDGE, Mass.–(BUSINESS WIRE)– RaNA Therapeutics tod...

CRISPR Therapeutics and Neon Therapeutics Enter Research Collaboration

CAMBRIDGE, Mass. and BASEL, Switzerland, July 10, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines...

Clinical Trials [119 Associated Clinical Trials listed on BioPortfolio]

Randomized Clinical Trial of Occlusal Sealant

This study assessed long-term impact of tooth Eruption Stages (ES) on sealant retention on occlusal surfaces previously coated with intermediary bonding layer and it determined caries inci...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1148 Associated Companies listed on BioPortfolio]

Chroma Therapeutics Ltd

Chroma Therapeutics is a privately-held biotechnology company focused on the discovery and development of novel small molecule drugs based upon chromatin biology. Chroma is the first company to system...

Chroma Technology Corp

Chroma Technology Corp. is a manufacturer of interference filters for the ultra-violet, visible and near-infrared portions of the spectrum, including bandpass, multiple bandpass, and long and short pa...

Chroma Technology Corp.

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

More Information about "Chroma Therapeutics Ltd" on BioPortfolio

We have published hundreds of Chroma Therapeutics Ltd news stories on BioPortfolio along with dozens of Chroma Therapeutics Ltd Clinical Trials and PubMed Articles about Chroma Therapeutics Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chroma Therapeutics Ltd Companies in our database. You can also find out about relevant Chroma Therapeutics Ltd Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record